Exploring the interaction of graphene-based nanomaterials with atherosclerosis-related protein targets: insights from molecular docking and dynamics simulations
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, Tokgözoğlu L, Lewis EF (2019) Atherosclerosis. Nat Rev Dis Primers 5:5610.1038/s41572-019-0106-z ↗
2. Orekhov AN (2018) LDL and foam cell formation as the basis of atherogenesis. Curr Opin Lipidol 29:279–28410.1097/MOL.0000000000000525 ↗
3. Cochain C, Zernecke A (2017) Macrophages in vascular inflammation and atherosclerosis, Pflug. Arch Eur J Physiol 469:485–49910.1007/s00424-017-1941-y ↗
4. Xu Z, Wei Z, Zhou JJ, Ye F, Lo WS, Wang F, Lau CF, Wu J, Nangle LA, Chiang KP, Yang XL, Zhang M, Schimmel P (2012) Internally deleted human tRNA synthetase suggests evolutionary pressure for repurposing. Structure 20:1470–1477. https://doi.org/10.1016/j.str.2012.06.00210.1016/j.str.2012.06.002 ↗
5. Remmerie A, Scott CL (2018) Macrophages and lipid metabolism. Cell Immunol 330:27–4210.1016/j.cellimm.2018.01.020 ↗
6. Geim A, Novoselov K (2007) The rise of graphene (editorial). Nat Mat 6:18310.1038/nmat1849 ↗
7. Li X, Tao L, ChenH Z, Fang X, Li X, Wang JB, Xu HZhu (2017) Graphene and related two-dimensional materials: structure-property relationships for electronics and optoelectronics. Appl Phys Rev 4:02130610.1063/1.4983646 ↗
8. Narayan R, Kim SK (2015) Surfactant mediated liquid phase exfoliation of graphene. Nano Convergence 2:2010.1186/s40580-015-0050-x ↗
9. Trikkaliotis DG, Christoforidis AK, Mitropoulos AC, Kyzas GZ (2021) Graphene oxide synthesis, properties and characterization techniques: a comprehensive review. Chem Eng 5:64
10. Priyadarsini S, Mohanty S, Mukherjee S, Basu S, Mishra M (2018) Graphene and graphene oxide as nanomaterials for medicine and biology application. J Nanostruct Chem 8:123–13710.1007/s40097-018-0265-6 ↗
11. Krivak R, Hoksza D (2018) P2Rank: Machine learning-based tool for rapid and accurate prediction of ligand binding sites from protein structure. J Cheminform 10(1):3910.1186/s13321-018-0285-8 ↗
12. Cousins KR (2011) Computer review of ChemDraw ultra 12.0. J Am Chem Soc 133(33):8388–838810.1021/ja204075s ↗
13. Momohjimoh OI, Abechi SE, Shallangwa GA (2021) Computational evaluation of some compounds as potential anti-breast cancer agents. Future J Pharma Sci 7:16710.1186/s43094-021-00315-2 ↗
14. Jakubec D, Skoda P, Krivak R, Novotny M, Hoksza D (2022) PrankWeb 3: Accelerated ligand-binding site predictions for experimental and modelled protein structures. Nucleic Acids Res 50:593–59710.1093/nar/gkac389 ↗
15. Trott O, Olson AJ (2010) AutoDockVina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–46110.1002/jcc.21334 ↗
16. Durrant JD, McCammon JA (2011) BINANA: A novel algorithm for ligand-binding characterization. J Mol Graph Model 29(6):888–89310.1016/j.jmgm.2011.01.004 ↗
17. Kudin KN, Ozbas B, Schniepp HC, Prud’homme RK, Aksay IA, Car R (2008) Raman spectra of graphite oxide and functionalized graphene sheets. Nano Lett 8(1):36–4110.1021/nl071822y ↗
18. Hu Y, Gao H (2023) Chemical synthesis of reduced graphene oxide: a review. Miner Miner Mater 2:810.20517/mmm.2023.07 ↗
19. Biru EI, Necolau MI, Zainea A, Iovu H (2022) Graphene oxide-protein-based scaffolds for tissue engineering: recent advances and applications. Polymers 14:103210.3390/polym14051032 ↗
20. Stankovich S, Dikin DA, Piner RD, Kohlhaas KA, Kleinhammes A, Jia Y, Wu Y, Nguyen ST, Ruoff RS (2007) Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. Carbon 45(7):1558–156510.1016/j.carbon.2007.02.034 ↗
21. Zhang CM (2016) Lieber, Nano-Bioelectronics. Chem Rev 116(1):49–9610.1021/acs.chemrev.5b00608 ↗
22. Rhainds D, Brissette L (2004) The role of scavenger receptor class B type I (SR-BI) in lipid trafficking: defining the rules for lipid traders. Int J Biochem Cell Biol 36(1):39–7710.1016/S1357-2725(03)00173-0 ↗
23. Park H, Adsit FG, Boyington JC (2005) The 1.4 Å Crystal structure of the human oxidized low density lipoprotein receptor LOX-1. J Biol Chem 280(14):13593–1359910.1074/jbc.M500768200 ↗
24. Bilinovich SM, Davis CM, Morris DL, Ray LA, Prokop JW, Buchan GJ, Leeper TC (2014) The C-terminal domain of SRA1p has a fold more similar to PRP18 than to an RRM and does not directly bind to the SRA1 RNA STR7 region. J Mol Biol 426(10):1753–176510.1016/j.jmb.2014.01.007 ↗
25. Zhou JJ, Wang F, Xu Z, Lo W-S, Lau C-F, Chiang KP, Nangle LA, Ashlock MA, Mendlein JD, Yang X-L, Zhang M, Schimmel P (2014) Secreted histidyl-tRNA synthetase splice variants elaborate major epitopes for autoantibodies in inflammatory myositis. J Biol Chem 289(28):19269–1927510.1074/jbc.C114.571026 ↗
26. Neculai N, Schwake M, Ravichandran M, Zunke F, Collins RF, Peters J, Neculai M, Plumb J, Loppnau P, Pizarro JC, Seitova A et al (2013) Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36. Nature 504(7478):172–17610.1038/nature12684 ↗
27. Novoselov KS, Geim AK, Morozov SV, Jiang D, Zhang Y, Dubonos SV, Grigorieva IV, Firsov AA (2004) Electric field effect in atomically thin carbon films. Science 306(5696):666–66910.1126/science.1102896 ↗
28. Jian JW, Elumalai P, Pitti T, Wu CY, Tsai KC, Chang JY, Peng HP, Yang AS (2016) Predicting ligand binding sites on protein surfaces by 3-dimensional probability density distributions of interacting atoms. PLoS One 11(8):01603110.1371/journal.pone.0160315 ↗
29. Wang Y, Li Z, Wang J, Li J, Lin Y (2011) Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol 29(5):205–21210.1016/j.tibtech.2011.01.008 ↗
30. Hasan SA, Rigueur JL, Harl RR, Krejci AJ, Isabel GJ, Rogers BR (2010) Transferable graphene oxide films with tunable microstructures. ACS Nano 4(12):7367–737210.1021/nn102152x ↗
31. Paredes JI, Villar-Rodil S, Martínez-Alonso A, Tascón JMD (2008) Graphene oxide dispersions in organic solvents. Langmuir 24:10560–1056410.1021/la801744a ↗
32. Dreyer DR, Park S, Bielawski CW, Ruoff RS (2010) The chemistry of graphene oxide. Chem Soc Rev 39:228–24010.1039/B917103G ↗
33. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785–279110.1002/jcc.21256 ↗
34. Aher A, Nickerson T, Jordan C, Thorpe F, Hatakeyama E, Ormsbee L, Majumder M, Bhattacharyya D (2020) Ion and organic transport in graphene oxide membranes: model development to difficult water remediation applications. J Membr Sci 604:11802410.1016/j.memsci.2020.118024 ↗
35. Ciric L, Sienkiewicz A, Gaal R, Jacimovic J, Vaju C, Magrez A, Forro L (2012) Defects and localization in chemically-derived graphene, Physical Review B: Condensed Matter and Materials. Physics 86:19
36. Liu J, Cui L, Losic D (2013) Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater 9:9243–925710.1016/j.actbio.2013.08.016 ↗
37. Trott O, Olson AJ (2010) AutoDockVina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455–46110.1002/jcc.21334 ↗
38. Meng XY, Zhang HX, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7(2):146–15710.2174/157340911795677602 ↗
39. Bagri A, Mattevi C, Acik M, Chabal YJ, Chhowalla M, Shenoy VB (2010) Structural evolution during the reduction of chemically derived graphene oxide. Nat Chem 2(7):581–58710.1038/nchem.686 ↗
40. Cauet E, Rooman M, Wintjens R, Lievin J, Biot C (2005) Histidine-aromatic interactions in proteins and protein-ligand complexes: quantum chemical study of X-ray and model structures. J Chem Theory Comput 1:472–48310.1021/ct049875k ↗
41. Speight JG (2020) Water chemistry. Natural Water Remediation 127–12810.1016/B978-0-12-803810-9.00003-6 ↗
42. Brylinski M (2018) Aromatic interactions at the ligand-protein interface: implications for the development of docking scoring functions. ChemBiol Drug Des 91(2):380–39010.1111/cbdd.13084 ↗
43. Panigrahi SK, Desiraju GR (2007) Strong and weak hydrogen bonds in the protein-ligand interface. Proteins. 67(1):128–141. https://doi.org/10.1002/prot.2125310.1002/prot.21253 ↗
44. Boehr DD, Farley AR, Wright GD, Cox JR (2002) Analysis of the pi-pi stacking interactions between the aminoglycoside antibiotic kinase APH(3′)-IIIa and its nucleotide ligands. Chem Biol 9:1209–121710.1016/S1074-5521(02)00245-4 ↗
45. Pyrkov TV, Pyrkova DV, Balitskaya ED, Efremov RG (2009) The role of stacking interactions in complexes of proteins with adenine and Guanine fragments of ligands. Acta Naturae 1:124–12710.32607/20758251-2009-1-1-124-127 ↗
46. Wu R, McMahon TB (2008) Investigation of cation-pi interactions in biological systems. J Am Chem Soc 130:12554–1255510.1021/ja802117s ↗
47. Efremov RG, Chugunov AO, Pyrkov TV, Priestle JP, Arseniev AS, Jacoby E (2007) Molecular lipophilicity in protein modeling and drug design. Curr Med Chem 14:393–41510.2174/092986707779941050 ↗
48. Gallina AM, Bork P, Bordo D (2014) Structural analysis of protein-ligand interactions: the binding of endogenous compounds and of synthetic drugs. J MolRecognit 27:65–7210.1002/jmr.2332 ↗
49. Lu Y, Wang Y, Zhu W (2010) Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design. PhysChemChem Phys 12:4543–4551
50. Zhou P, Tian F, Zou J, Shang Z (2010) Rediscovery of halogen bonds in protein-ligand complexes. Mini Rev Med Chem 10:309–31410.2174/138955710791331016 ↗
51. Kukic P, Nielsen JE (2010) Electrostatics in proteins and protein-ligand complexes, Future. Med Chem 2:647–666
52. Zhou P, Huang J, Tian F (2012) Specific noncovalent interactions at protein-ligand interface: implications for rational drug design. Curr Med Chem 19:226–23810.2174/092986712803414150 ↗
53. Chen K, Kurgan L (2009) Investigation of atomic level patterns in protein–small ligand interactions. PLoS One 4:447310.1371/journal.pone.0004473 ↗
54. Shahriari S, Sastry M, Panjikar S, Singh Raman RK (2021) Graphene and graphene oxide as a support for biomolecules in the development of biosensors. Mater Sci Eng C 118:111546
55. Chen SH, Bell DR, Luan B (2022) Understanding interactions between biomolecules and two-dimensional nanomaterials using in silico microscopes. Adv Drug Deliv Rev 186:11433610.1016/j.addr.2022.114336 ↗
56. Kumar SR, Hsu Y-H, Vi TTT, Pang J-HS, Lee Y-C, Hsieh C-H, Lue SJ (2021) Graphene oxide-induced protein conformational change in nasopharyngeal carcinoma cells: a joint research on cytotoxicity and photon therapy. Materials (Basel) 14(6):139610.3390/ma14061396 ↗
57. Park BS, Song DH, Kim HM, Choi B-S, Lee H, Lee J-O (2009) The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex. Nature 458:1191–119510.1038/nature07830 ↗
58. Dasari TP, McShan S, Dasmahapatra AK, Tchounwou PB (2018) A review on graphene-based nanomaterials in biomedical applications and risks in environment and health. Nano-Micro Lett 10(3):5310.1007/s40820-018-0206-4 ↗
59. Casalini T, Limongelli V, Schmutz M, Som C, Jordan O, Wick P, Borchard G, Perale G (2019) Molecular modeling for nanomaterial–biology interactions: opportunities, challenges, and perspectives. Front Bioeng Biotechnol 7:26810.3389/fbioe.2019.00268 ↗
60. Tuffery P, Derreumaux P (2012) Flexibility and binding affinity in protein–ligand, protein–protein and multi-component protein interactions: limitations of current computational approaches. J R Soc Interface 9(66):20–3310.1098/rsif.2011.0584 ↗
61. Chaudhary K, Kumar K, Venkatesu P, Masram DT (2021) Protein immobilization on graphene oxide or reduced graphene oxide surface and their applications: influence over activity, structural and thermal stability of protein. Adv Colloid Interface Sci 289:10236710.1016/j.cis.2021.102367 ↗
62. Boehr DD, Nussinov R, Wright PE (2009) The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol 5(11):789–79610.1038/nchembio.232 ↗
63. Wlodawer A, Minor W, Dauter Z, Jaskolski M (2008) Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures. FEBS J 275(1):1–2110.1111/j.1742-4658.2007.06178.x ↗
64. Chen GY, Pang DW, Hwang SM, Tuan HY, Hu YC (2012) A graphene-based platform for induced pluripotent stem cells culture and differentiation. Biomaterials 33(2):418–42710.1016/j.biomaterials.2011.09.071 ↗
65. Gough PJ, Gordon S (2000) The role of scavenger receptors in the innate immune system. Microbes Infect 2(3):305–31110.1016/S1286-4579(00)00297-5 ↗